Nationwide Recall of 40,000 Eye Drop Bottles Amid Sterility Concerns

Financial analyst Jeff Sica appeared on Fox Business with Stuart Varney to discuss recent retail earnings from Home Depot and Walmart, evaluating consumer health trends, real estate dynamics, and inflation’s impact on the home improvement sector.

A total of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops, manufactured by Prestige Brand Holdings in Tarrytown, New York, are being voluntarily recalled nationwide due to potential contamination, according to the U.S. Food and Drug Administration. The recall follows an FDA enforcement report indicating a “lack of assurance of sterility.”

The affected product consists of 15‑milliliter bottles labeled with lot code 2552A and an expiration date of September 30, 2027, and was distributed by Medtech Products Inc., a subsidiary of Prestige Consumer Healthcare.

NEARLY 12 MILLION BOTTLES OF ROHTO EYE DROPS RECALLED OVER STERILITY CONCERNS, FDA ANNOUNCES

Approximately 40,000 eye drop bottles are being recalled nationwide due to potential contamination. (Getty Images)

The FDA classified the recall as a Class II recall, which it defines as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

MILLIONS OF PRESCRIPTION EYE DROPS RECALLED NATIONWIDE OVER CONTAMINATION CONCERNS

The FDA classified the recall as a Class II recall. (Getty Images)

The company completed the acquisition of the Breathe Right brand – known for its nasal strips – and other assets from Foundation Consumer Healthcare in June, in a transaction valued at approximately $1.05 billion.

Other brands in the Prestige portfolio include Dramamine, Luden’s and Anacin.

FOX Business reached out to Prestige Brands for comment.

Source link